HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HBW Insight Team

Latest From HBW Insight Team

Advertising Law In 2024: Attorneys Tuning In For ‘Clean Beauty,’ ‘Dark Patterns’ Developments

Attorneys are watching how the Federal Trade Commission and other authorities address online marketing practices this year that are increasingly viewed as potentially harmful to consumers.

Advertising, Marketing & Sales Legal Issues

Wellness In 2024: Expect Growth Fueled By Digital And AI-Powered Personalization

Wellness industry leaders and experts on key trends and priorities in 2024.

Dietary Supplements Ingredients

Beauty In 2024: Driving Industry Growth And Innovation In An Increasingly Regulated World

Trade association leaders and industry experts highlight priorities for the year ahead, from tackling mounting sustainability and green science challenges to meeting new MoCRA requirements and educating European policymakers, new and old, on the cosmetics industry’s value and needs.

Regulation Compliance

Association Focus In 2024: Self-Care, Sustainability And Prospects For Political ‘Reorientation’

Association leaders offer views on key challenges, priorities and opportunities for the self-care industry in 2024, including potential political redirections following elections in the US and Europe.

Regulation Legislation

Consumer Health In 2024: ‘Switch Power,’ ‘Reframing Sustainability’ And Meeting Household Budgets

Views from industry leaders and experts on the biggest trends, challenges and opportunities facing consumer health in the new year.

Prescription To OTC Switch Digital Health

ESG In 2024: Stakeholder Views From ‘Strategic Imperative’ To ‘Largely A Nonsense’

HBW Insight and Medtech Insight reached out to industry stakeholders for feedback on new climate-related disclosure requirements and growing environmental, social and governance (ESG) pressures on businesses.

Regulation Sustainability
See All
UsernamePublicRestriction

Register